4//SEC Filing
Landry Robert E 4
Accession 0001968202-24-000053
CIK 0000872589other
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 4:08 PM ET
Size
8.8 KB
Accession
0001968202-24-000053
Insider Transaction Report
Form 4
Landry Robert E
SVP Fin, Dep CFO
Transactions
- Tax Payment
Common Stock
2024-02-02$956.65/sh−281$268,819→ 23,693 total - Exercise/Conversion
Common Stock
2024-02-02$378.98/sh+400$151,592→ 23,974 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2024-02-02−400→ 11,787 totalExercise: $378.98Exp: 2027-12-12→ Common Stock (400 underlying)
Holdings
- 270(indirect: By 401(k))
Common Stock
Footnotes (1)
- [F1]The stock option award vests in four equal annual installments, commencing one year after the date of grant.
Documents
Issuer
REGENERON PHARMACEUTICALS, INC.
CIK 0000872589
Entity typeother
Related Parties
1- filerCIK 0001585160
Filing Metadata
- Form type
- 4
- Filed
- Feb 5, 7:00 PM ET
- Accepted
- Feb 6, 4:08 PM ET
- Size
- 8.8 KB